Prostate Cancer Registries: Current Status and Future Directions. Read more about Prostate Cancer Registries: Current Status and Future Directions.
Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Read more about Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.
Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302. Read more about Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302.
Postprostatectomy Radiotherapy for Patients with High-risk Features on Definitive Pathology: A Plea for Evidence-based Medicine. Read more about Postprostatectomy Radiotherapy for Patients with High-risk Features on Definitive Pathology: A Plea for Evidence-based Medicine.
Genomic Predictors of Outcome in Prostate Cancer. Read more about Genomic Predictors of Outcome in Prostate Cancer.
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator. Read more about Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator.
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death. Read more about Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.
Impact of age on quality-of-life outcomes after treatment for localized prostate cancer. Read more about Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
Active surveillance for low-risk prostate cancer: developments to date. Read more about Active surveillance for low-risk prostate cancer: developments to date.
Natural History after Biochemical Failure Following Dose-escalated External Beam Radiation: An Opportunity to Improve Outcomes? Read more about Natural History after Biochemical Failure Following Dose-escalated External Beam Radiation: An Opportunity to Improve Outcomes?
